Suppr超能文献

正在考虑停止惊恐障碍的治疗。

Thinking about stopping treatment for panic disorder.

作者信息

DuPont R L

机构信息

Institute for Behavior and Health Inc., Rockville, MD 20852.

出版信息

J Clin Psychiatry. 1990 Dec;51 Suppl A:38-45.

PMID:2258376
Abstract

The lifelong nature of panic disorder and the development of effective new treatments have focused attention on long-term use of antipanic medications, particularly benzodiazepines and their possibly addictive nature. Benzodiazepines are generally safe and effective. An understanding of the distinction between chemical dependence and physical dependence places problems involved in the use and discontinuation of benzodiazepines into perspective. Patients with a dual diagnosis of panic disorder and chemical dependence are at risk of addiction. Others may develop physical dependence but are able to discontinue benzodiazepine treatment when panic symptoms subside. The approach to benzodiazepine use and discontinuation should be different for patients with chemical dependence as opposed to patients with physical dependence. A four-step approach to discontinuation that is applicable to both groups is offered.

摘要

惊恐障碍的终身性以及有效新疗法的发展,使得人们将注意力集中在抗惊恐药物的长期使用上,尤其是苯二氮䓬类药物及其可能的成瘾性。苯二氮䓬类药物总体上安全有效。理解化学依赖和身体依赖之间的区别,能正确看待使用和停用苯二氮䓬类药物所涉及的问题。患有惊恐障碍和化学依赖双重诊断的患者有成瘾风险。其他患者可能会产生身体依赖,但在惊恐症状消退后能够停用苯二氮䓬类药物治疗。对于化学依赖患者与身体依赖患者,苯二氮䓬类药物的使用和停用方法应有所不同。本文提供了一种适用于这两类患者的四步停药方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验